CME Group (CME) Gets a Hold from Barclays

In a report released on April 10, Benjamin Budish from Barclays maintained a Hold rating on CME Group, with a price target of $343.00. The company’s shares closed last Friday at $295.30.

Claim 30% Off TipRanks

• Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
• Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Budish covers the Financial sector, focusing on stocks such as Robinhood, Coinbase Global, and Apollo Global Management. According to TipRanks, Budish has an average return of 7.9% and a 55.05% success rate on recommended stocks.

In addition to Barclays, CME Group also received a Hold from KBW’s Kyle Voigt in a report issued on April 8. However, on April 10, Morgan Stanley assigned a Buy rating to CME Group (NASDAQ: CME).

Based on CME Group’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $1.65 billion and a net profit of $1.17 billion. In comparison, last year the company earned a revenue of $1.53 billion and had a net profit of $874.6 million

Based on the recent corporate insider activity of 94 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of CME in relation to earlier this year. Last month, Elizabeth Cook, a Director at CME sold 1,000.00 shares for a total of $320,000.00.